NO20030165L - Fremgangsmåte for å adskille molekyl¶re former - Google Patents

Fremgangsmåte for å adskille molekyl¶re former

Info

Publication number
NO20030165L
NO20030165L NO20030165A NO20030165A NO20030165L NO 20030165 L NO20030165 L NO 20030165L NO 20030165 A NO20030165 A NO 20030165A NO 20030165 A NO20030165 A NO 20030165A NO 20030165 L NO20030165 L NO 20030165L
Authority
NO
Norway
Prior art keywords
molecules
molecular forms
separating molecular
pathogenic
aggregated protein
Prior art date
Application number
NO20030165A
Other languages
English (en)
Other versions
NO20030165D0 (no
Inventor
Stuart Mark Wilson
Christopher John Stanley
Original Assignee
Microsens Biophage Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microsens Biophage Ltd filed Critical Microsens Biophage Ltd
Publication of NO20030165D0 publication Critical patent/NO20030165D0/no
Publication of NO20030165L publication Critical patent/NO20030165L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/6818—Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20030165A 2000-07-11 2003-01-13 Fremgangsmåte for å adskille molekyl¶re former NO20030165L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0016953.2A GB0016953D0 (en) 2000-07-11 2000-07-11 A method for distinguishing aggregated or polymerised forms of a given molecule from the unaggregated or unpolymerised form
PCT/GB2001/003074 WO2002004948A2 (en) 2000-07-11 2001-07-11 Distinguishing molecular forms

Publications (2)

Publication Number Publication Date
NO20030165D0 NO20030165D0 (no) 2003-01-13
NO20030165L true NO20030165L (no) 2003-03-10

Family

ID=9895395

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030165A NO20030165L (no) 2000-07-11 2003-01-13 Fremgangsmåte for å adskille molekyl¶re former

Country Status (11)

Country Link
US (1) US20040038200A1 (no)
EP (1) EP1368655B1 (no)
JP (1) JP2004512500A (no)
AT (1) ATE357659T1 (no)
AU (2) AU2001270773B2 (no)
CA (1) CA2415639A1 (no)
DE (1) DE60127460T2 (no)
GB (1) GB0016953D0 (no)
NO (1) NO20030165L (no)
NZ (1) NZ524077A (no)
WO (1) WO2002004948A2 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE504798C2 (sv) * 1995-06-16 1997-04-28 Ulf Landegren Immunanalys och testkit med två reagens som kan tvärbindas om de adsorberats till analyten
GB0126976D0 (en) * 2001-11-09 2002-01-02 Microsens Biophage Ltd Multiple virus reaction assay
US20070281367A1 (en) 2006-05-03 2007-12-06 Applera Corporation Methods, Compositions, and Kits for Quantitating Antibodies
US20130224282A1 (en) * 2010-09-21 2013-08-29 Massachusetts Institute Of Technology Multistage Nanoparticles

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727022A (en) * 1984-03-14 1988-02-23 Syntex (U.S.A.) Inc. Methods for modulating ligand-receptor interactions and their application
JP2681370B2 (ja) * 1988-06-30 1997-11-26 塩野義製薬株式会社 免疫測定法
EP0439354A3 (en) * 1990-01-24 1992-06-17 Amoco Corporation Signal generating moiety and method for use
US5635602A (en) * 1993-08-13 1997-06-03 The Regents Of The University Of California Design and synthesis of bispecific DNA-antibody conjugates
DE69928250T2 (de) * 1998-06-04 2006-08-03 Microsens Biophage Ltd. Analytisches verfahren unter verwendung von multipelviren-markierung
EP1216417A1 (de) * 1999-09-28 2002-06-26 Evotec OAI AG Quantitative analyse und typisierung subzellulärer partikel

Also Published As

Publication number Publication date
EP1368655B1 (en) 2007-03-21
WO2002004948A2 (en) 2002-01-17
US20040038200A1 (en) 2004-02-26
DE60127460D1 (de) 2007-05-03
AU2001270773B2 (en) 2005-11-17
WO2002004948A3 (en) 2003-10-02
NZ524077A (en) 2005-06-24
CA2415639A1 (en) 2002-01-17
DE60127460T2 (de) 2007-12-06
AU7077301A (en) 2002-01-21
ATE357659T1 (de) 2007-04-15
GB0016953D0 (en) 2000-08-30
NO20030165D0 (no) 2003-01-13
JP2004512500A (ja) 2004-04-22
EP1368655A2 (en) 2003-12-10

Similar Documents

Publication Publication Date Title
CY1109554T1 (el) Μεθοδοι και αντιδραστηρια για την ανιχνευση ενδοτοξινης
BRPI0412184A (pt) renderização de anúncios com documentos tendo um ou mais tópicos utilizando informação de interesse de tópico do usuário
BR0313739A (pt) Método para minimizar a possibilidade de resultados falso-positivos e falso-negativos na detecção de pequenas quantidades de lìquido amniótico em secreção vaginal e dispositivo para realizar o método
DE60132311D1 (de) Funktionalisierte eingekapselte fluoreszierende nanokristalle
BR0108429A (pt) Sistema para facilitar o processamento e gerenciamento de transações
ATE464374T1 (de) Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen
BR9814309A (pt) Geração automática de configuração
KR920001332A (ko) 고성능 프로세서의 브랜치 예상 동작 방법 및 장치
ATE385259T1 (de) Verfahren zum nachweis von influenza a/b-viren in speichel
ATE299594T1 (de) Verbesserungen von screeningsverfahren für papillomviren
FR2809181B1 (fr) Monoreactif pour le dosage des microparticules plaquettaires
NO20030165D0 (no) Fremgangsmåte for å adskille molekyl¶re former
WO2003014926A3 (en) Victim selection for deadlock detection
NO20052553D0 (no) Cobalaminanalyse.
ATE409917T1 (de) System und verfahren zum optimierten parsen von tag-basierten protokollströmen
BR9903250A (pt) Antìgenos e imunoanálises para diagnóstico da doença de chagas.
ATE335816T1 (de) Verfahren zum nachweis prokaryontischer dna
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
DE69606024T2 (de) Feststellung von antikörperproduktion
BRPI0412372A (pt) reagentes, métodos e kits para detectar enzimas da alimentação
DE60223133D1 (de) Verfahren zum lokalisieren und identifizieren von epitopen
ATE389179T1 (de) Verfahren und kit zum nachweis von antigenen
DE50113417D1 (de) Zellbindende nukleinsäuremoleküle (aptamere)
BR0316440A (pt) Processo para a polimerização de radical livre na presença de um regulador e uso dos compostos
ATE258347T1 (de) Tandemaudiokompression

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application